A SEER-based analysis estimated the risk of<unk>  in Chronic Lymphocytic Leukemia (CLL) patients in the United States to be about 0.72%. The majority of<unk> s (85%) were Diffuse Large B-Cell Lymphoma (DLBCL), while<unk>  to Hodgkin occurred in 15% of cases. Most of those<unk>  events were nodal (74%). The most commonly involved extra-nodal sites were the GI tract (25%), skeletal system (19%), and the brain/CNS (12%). The median time from the diagnosis of CLL to the development of<unk>  was about 4 years, with no significant difference in the time interval based on histology of the<unk>  event comparing DLBCL and Hodgkin's. The median age at the time of<unk>  was 66 years.
Richter's transformation
Lupus nephritis
Shunt nephritis
Phosphate nephropathy
Benign nephrosclerosis
Analgesic nephropathy
IgA nephropathy
Myeloma cast nephropathy